Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Brain Eye Amyloid Memory (BEAM) Study: Validation of Ocular Measures as Potential Biomarkers for Early Detection of Brain Amyloid and Neurodegeneration

NCT02524405 is registered in ClinicalTrials.gov with Sunnybrook Health Sciences Centre as lead sponsor.

NCT NCT02524405
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02524405 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Brain Eye Amyloid Memory (BEAM) Study: Validation of Ocular Measures as Potential Biomarkers for Early Detection of Brain Amyloid and Neurodegeneration
Lead sponsor
Sunnybrook Health Sciences Centre
Phase
Observational
Overall status
Unknown status
Start date
February 29, 2016
Completion date
March 31, 2025
Enrollment
345 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease, lewy body disease, mild cognitive impairment, parkinson's disease, vascular cognitive impairment